Skip to content
PICO Portalanswers from OpenAlex

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease

PaperCitations, authors & open-access status

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease is a paper indexed in PICO Portal from OpenAlex.

How many citations does Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease have?

PICO Portalcitation count

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease has 435 citations in the OpenAlex counts PICO Portal stores.

When was Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease published?

PICO Portalyear

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease has 2007 year in the PICO Portal index.

What is the open-access status of Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease?

PICO Portaloa status

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease has closed oa status in the PICO Portal index.

What is the DOI of Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease?

PICO Portaldoi

The DOI for Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease is on the source record.

What is the PMID of Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease?

PICO Portalpmid

The PMID for Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease is on the source record.

What is the OpenAlex record for Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease?

PICO Portalopenalex

The OpenAlex for Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial